home / stock / neph / neph news

NEPH News and Press, Nephros Inc. From 02/27/20

Stock Information
Company Name: Nephros Inc.
Stock Symbol: NEPH
Market: OTC
Website: nephros.com
Menu
NEPH NEPH Quote NEPH Short NEPH News NEPH Articles NEPH Message Board
Get NEPH Alerts

News, Short Squeeze, Breakout and More Instantly...
NEPH - Nephros Reports 2019 Fourth Quarter and Full Year Financial Results

Fourth Quarter Net Revenue up 96%; Annual Net Revenue up 82% Establishes 2020 Revenue Guidance at $14.5 to $15.5 Million SOUTH ORANGE, N.J., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq:NEPH), a commercial stage company that develops and sells high performance water purific...
NEPH - Nephros Announces Fourth Quarter and Full Year 2019 Financial Results Conference Call

SOUTH ORANGE, NJ, Feb. 20, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced that it...

NEPH - Nephros down 11% premarket after pricing equity offering

Nephros (NASDAQ: NEPH ) has priced its public offering of 937,500 common stock at $8.00 per share, for gross proceeds of ~$7.5M. More news on: Nephros, Inc., Healthcare stocks news, , Stocks on the move, Read more ...

NEPH - Nephros Announces Pricing of $7.5 Million Underwritten Offering of Common Stock

SOUTH ORANGE, NJ, Jan. 31, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nephros, Inc. (Nasdaq: NEPH) (“Nephros” or the “Company”), a  commercial-stage company that develops and sells high performance water purification products and pathogen detection...
NEPH - Nephros Announces Launch of PluraPath(TM), a Real-Time, Portable, Water Pathogen Detection System

SOUTH ORANGE, NJ, Jan. 09, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical device and commercial markets, today announced ...

NEPH - Nephros updates preliminary FY 2019 results

Nephros (NASDAQ: NEPH ) reports preliminary Q4 and FY 2019 financial results. More news on: Nephros, Inc., Healthcare stocks news, Read more ...

NEPH - Nephros Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2019

Anticipates $10.3 Million Full-Year Revenue, Approximately 82% Growth Over 2018; Fourth Quarter Year-Over-Year Revenue Growth Approximately 99% SOUTH ORANGE, NJ, Jan. 06, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company th...
NEPH - Mixed shelf roundup - healthcare

The following companies have filed for mixed shelf offerings: More news on: Nephros, Inc., Voyager Therapeutics, Inc., Allogene Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...

NEPH - Nephros EPS in-line, misses on revenue

Nephros (NASDAQ: NEPH ): Q3 GAAP EPS of -$0.10 in-line. More news on: Nephros, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

NEPH - Nephros Reports Third Quarter Financial Results

Product Revenue up 85% over Q3 2018 Reiterates Full-Year Revenue Guidance of $9.5-10 Million SOUTH ORANGE, NJ, Nov. 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq:NEPH), a commercial stage company that develops and sells high performance water purification produ...
Previous 10 Next 10